Latest news
GSK Looks 19.3% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocusGuruFocus · Wed, 29 Jul 2026 22:18:58 GMTGSK’s ADC prospects brighten further with Hansoh’s second Phase III triumph - Clinical Trials ArenaClinical Trials Arena · Wed, 29 Jul 2026 07:00:00 GMTGSK Looks 17.2% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocusGuruFocus · Tue, 28 Jul 2026 07:00:00 GMT